\
&
Contact us
\
&
Contact us
Published on | 6 months ago
Programmes EITThe European Commission wants contracting authorities to take up a more R&D intensive approach and contribute to the take-up of innovative products. To this purpose they have set-up a large initiative on Pre-commercial Procurement (PCP) and Public Procurement of Innovation (PPI). Some of these calls are launched within the Horizon Europe Framework. More information can be found on this infosheet. These are the PCP and PPI calls from the Horizon Europe Work Programma 2025
CSA Actions:
PCP Actions
For those who are interested which calls will open in 2026, these are the proposed topics:
PCP Actions
PPI Actions
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
